Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering
Hand-out
Press Releases
Citius Pharmaceuticals, Inc.  
November 18, 2024

Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering

CRANFORD, N.J., Nov. 18, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care

avatar profile Olean Times Herald

Olean Times Herald


Local & Social